Clinical trials
Withdrawn Observational Myelodysplastic Syndromes trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
8 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 1 |
| 2008 | 1 |
| 2017 | 2 |
| 2018 | 1 |
| 2020 | 1 |
| 2021 | 1 |
| 2024 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Withdrawn | 8 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Bristol-Myers Squibb | 1 |
| Grupo Cooperativo de Hemopatías Malignas | 1 |
| National Cancer Institute (NCI) | 1 |
| Rutgers, The State University of New Jersey | 1 |
| The Cleveland Clinic | 1 |
| Thomas Jefferson University | 1 |
| University of Florida | 1 |
| University of Medicine and Dentistry of New Jersey | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Myelodysplastic Syndromes | 8 |
| Leukemia, Myeloid, Acute | 5 |
| Burkitt Lymphoma | 2 |
| Central Nervous System Neoplasms | 2 |
| Congenital Abnormalities | 2 |
| Hodgkin Disease | 2 |
| Immunoblastic Lymphadenopathy | 2 |
| Immunoglobulin Light-chain Amyloidosis | 2 |
| Intraocular Lymphoma | 2 |
| Leukemia | 2 |
Trials
Showing 1 to 8 of 8. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.